National Heart, Lung, and Blood Institute (NHLBI) strategic visioning setting an agenda together for the NHLBI of 2025

Circulation

Volumn 131, Issue 12, 2015, Pages 1106-1109

  Lauer, Michael S ^a   Kiley, James P ^a   Mockrin, Stephen C ^a   Mensah, George A ^a   Hoots, W Keith ^a   Patel, Yasin ^a   Cook, Nakela L ^a   Patterson, Amy P ^b   Gibbons, Gary H ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood; Heart; Lung; Sleep

Indexed keywords

ARTICLE; BASIC RESEARCH; COMMUNITY CARE; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; HUMAN; MEDICAL RESEARCH; ORGANIZATION; PROCEDURES; TRENDS; UNITED STATES;

BIOMEDICAL RESEARCH; HUMANS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); ORGANIZATIONAL OBJECTIVES; UNITED STATES;

EID: 84929379216     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.015712     Document Type: Article

References (15)

1. Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383:999-1008. doi: 10.1016/S0140-6736(13)61752-3.
2. Nair P. Brown and Goldstein: the cholesterol chronicles. Proc Natl Acad Sci U S A. 2013;110:14829-14832. doi: 10.1073/pnas.1315180110.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1968-1978: CDC WONDER Online Database, compiled from Compressed Mortality File CMF 1968-1988, Series 20, No. 2A, 2000. http://wonder.cdc.gov/cmf-icd8.html. Accessed January 12, 2015.
4. National Vital Statistics Report (NVSR). Deaths: Final Data for 2013. NVSR Volume 64, Number 2. Table 16. http://www.cdc.gov/nchs/products/nvsr.htm. Accessed February 4, 2015.
5. TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA,Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox CS, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O'Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014;371:22-31.
6. Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ES, Fuster V, Fisher EA, Fayad ZA, Mulder WJ. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun. 2014;5:3065. doi: 10.1038/ncomms4065.
7. Galbán CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galbán S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711-1715. doi: 10.1038/nm.2971.
8. Castaldi PJ, Dy J, Ross J, Chang Y, Washko GR, Curran-Everett D, Williams A, Lynch DA, Make BJ, Crapo JD, Bowler RP, Regan EA, Hokanson JE, Kinney GL, Han MK, Soler X, Ramsdell JW, Barr RG, Foreman M, van Beek E, Casaburi R, Criner GJ, Lutz SM, Rennard SI, Santorico S, Sciurba FC, DeMeo DL, Hersh CP, Silverman EK, Cho MH. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax. 2014;69:415-422. doi: 10.1136/thoraxjnl-2013-203601.
9. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312:1033-1048. doi: 10.1001/jama.2014.10517.
10. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591-608.
11. National Center for Health Statistics. Health, United States, 2013: with special feature on prescription drugs. 2014. http://www.cdc.gov/nchs/data/hus/hus13.pdf. Accessed February 4, 2015.
12. US Department of Health and Human Services. 2013 National Healthcare Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; 2014. http://www.ahrq.gov/research/findings/nhqrdr/nhqr13/2013nhqr.pdf. Accessed February 4, 2015.
13. Collins FS. Research agenda: opportunities for research and NIH. Science. 2010;327:36-37. doi: 10.1126/science.1185055. Accessed February 4, 2015.
14. National Heart, Lung, and Blood Institute. NHLBI Strategic Plan. 2007. http://www.nhlbi.nih.gov/about/strategicplan/index.htm. Accessed February 4, 2015.
15. National Heart, Lung, and Blood Institute. Strategic Visioning: Charting Our Future Together. http://strategicvisioning.nhlbi.nih.gov. Accessed February 4, 2015.